Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 760 participants.

Also called NCT07929467

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 760 participants (planned count) (from the registry)
Sponsor
Karl Landsteiner University of Health Sciences (from the registry)
Registry
  • NCT NCT07929467
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07929467. Randomized; no masking; primary purpose treatment. Start 2027-11 (anticipated); primary completion 2029-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart Failure
Acronym
LEAP HF
Condition
Bradycardia
Condition
Atrioventricular Block
Condition
Heart Failure
Condition
Pacing Induced Cardiomyopathy
Condition
Pacing Therapy
Condition
Pacing Induced Dyssynchrony
Condition
Leadless Pacemaker
Intervention (Device)
Leadless pacemaker implantation
Intervention (Device)
Conventional transvenous pacemaker implantation
Lead sponsor
Karl Landsteiner University of Health Sciences (class: other)

Record details

Record id
cardio:ct-nct07929467
Content hash
d035ca0ef4182d9335a36b3b20e1b725acd1673406bf948efbaf463482c96312